AlphaYouTK
Congress trade
Rep. Thomas Kean (R-NJ) sold $15K-$50K of Johnson & Johnson (JNJ) stock
Thomas Kean, U.S. Representative (R-NJ), disclosed a sale of Johnson & Johnson (JNJ) stock worth $15K-$50K in a STOCK Act filing on Dec 19, 2025.
The trade happened on Nov 20, 2025, 29 days before it was made public.
JNJ has moved +30.4% since the trade date, from $203.07 to $264.74 (Sep 30, 2026 close).
- Traded
- Nov 20, 2025
- Disclosed
- Dec 19, 2025
- Filing delay
- 29 days
- Price since
- +30.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
More JNJ insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.